Catalent - Greenville Campus
Pharmaceutical Companies
Greenville, NC
7 found · ← All categories in Pitt
Updated October 31, 2026
Pharmaceutical Companies
Greenville, NC
Pharmaceutical Companies
Greenville, NC
Pharmaceutical Companies
Greenville, NC
Amalgent Therapeutics develops AMGT-0220, a fixed-dose opioid/pramipexole combination supported by a 2024 pilot study and three issued U.S. patents.
Pharmaceutical Companies
Greenville, NC
Patheon High Point Manufacturing Facility Site supports APIs, oral solid doses, softgels, steriles, and end-to-end CDMO services.
Express development solutions designed to reach clinical milestones faster
Pharmaceutical Companies
Greenville, NC
BioPharma Crescent connects biopharma manufacturers with sites across five North Carolina counties and a regional workforce exceeding 10,000 employees.
Help companies get up and running as quickly as possible
Pharmaceutical Companies
Farmville, NC
Pharmaceutical Companies
Greenville, NC
No. These listings primarily represent drug development, manufacturing, research, and site-selection services. Amalgent Therapeutics specifically advises that it does not provide patient prescriptions or retail medication dispensing.
Match the provider's capabilities to the project, such as API production, oral solid doses, sterile manufacturing, clinical supply, packaging, or logistics. Also confirm the required development stage and whether the company can support a transition from clinical work to commercial manufacturing.
Timing depends on the product, development stage, regulatory requirements, and manufacturing scale. Patheon lists express sterile-development solutions and timeline commitments, but a project-specific schedule requires a direct assessment.
No. Amalgent Therapeutics is focused on therapeutic development and licensing around opioid-related products, not emergency treatment. Immediate pain needs should be handled by a medical provider or emergency service.